middle.news
Integral Diagnostics Reports 25% Revenue Growth and Appoints New CFO
9:05am on Monday 10th of August, 2026 AEST
•
Healthcare
Read Story
Integral Diagnostics Reports 25% Revenue Growth and Appoints New CFO
9:05am on Monday 10th of August, 2026 AEST
Key Points
FY26 revenue expected around $788m-$790m, up 25%
Operating EBITDA forecast at $164m-$165m, 30% increase
Operating NPAT projected to rise 50% to $47m-$48m
Net debt to EBITDA ratio improves to 2.3x
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Integral Diagnostics (ASX:IDX)
OPEN ARTICLE